Alector (ALEC) Net Equity Issued and Repurchased (2018 - 2025)
Alector's (ALEC) quarterly Net Equity Issued and Repurchased came in at $5.3 million in Q4 2025, down 91.56% quarter-over-quarter from $62.6 million in Q3 2018.
Powered by 
Analysis
Alector (ALEC) Net Equity Issued and Repurchased (2018 - 2025) Analysis & Trends
Alector (ALEC) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $5.3 million the latest figure, recorded in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 9.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 49.20 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | - |